Overview
Taro Ohba practices practicing medicine in Funabashi, Japan.
His clinical expertise encompasses Lung Adenocarcinoma, EGFR Positive Lung Cancer, Lung Cancer, and Non-Small Cell Lung Cancer (NSCLC).
He is actively involved in clinical research, co-authoring 13 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Taro Ohba
Is Taro Ohba a top-rated expert for Lung Adenocarcinoma?
MediFind is an objective health platform that identifies experts based on real-world data. Taro Ohba is classified as an Experienced expert for Lung Adenocarcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Taro Ohba participate in research or clinical trials?
Yes. Taro Ohba has published 13 articles and abstracts on conditions like Lung Adenocarcinoma. You can view a list of Taro Ohba's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- EGFR Positive Lung CancerMr. Ohba isExperienced. Learn about EGFR Positive Lung Cancer.
- Lung AdenocarcinomaMr. Ohba isExperienced. Learn about Lung Adenocarcinoma.
- Lung CancerMr. Ohba isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Mr. Ohba isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).